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1-Supplemental synthetic schemes 
 
HO
H
N
O
O
HO
NH2
1
O
NC
O
NHBoc
O
NC
O
NH3Cl
2 3 4
i ii iii
 
 
Scheme S1: Reagents and conditions: (i) ethanolamine, Boc2O, TEA, DCM, 0°C, 2 h; (ii) 
cyanoacetic acid, DCC, THF, 0°C to RT, 24 h; (iii) HCl gas  passed through the ether solution of 
cmpd 3, 65 % overall yield. 
 
 
N
B
N
F F
HO
O
H
N
OO O
+
N
B
N
F F
O
O
N
O
O
N
B
N
F F
N
H
O
O
NC
O
7 85 6
i ii iii
CN-BOT  
Scheme S2: Reagents and conditions: (i) BF3.OEt2, THF, reflux for 5 h, RT for 24 h, 16 %; (ii) 
NHS, DCC, THF, RT, 5 h, 99 %; (iii) 4, TEA, DMF, RT, 24 h, 85 %. 
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Scheme S3: Reagents and conditions: (i) 4, TEA, DMF, RT, 24 h, 80%. 
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2-Summary of Generic Analytical and Chromatographic Conditions 
 
All reactions were performed in flame-dried glassware under a nitrogen atmosphere with dry 
solvents, unless noted otherwise. All reagents and starting materials were purchased from: 
Sigma Aldrich, Alpha Aesar or Acros Organic and used without further purification. 
 
Flash column chromatography was carried out using Merck 60 Kieselgel (230–400 mesh) under 
pressure. Analytical thin layer chromatography (TLC) was performed on aluminum plates pre-
coated with Merck silica gel 60 F254, and visualized by ultra-violet irradiation or by staining with 
aqueous acidic ammonium hexamolybdate, or aqueous acidic potassium permanganate 
solutions as appropriate.  
 
1H, 13C nuclear magnetic resonance (NMR) spectra were obtained as either CDCl3, CD3OD or 
DMSO-d6 solutions and recorded at 300 MHz, 75 MHz on Bruker Avance DPX 300 NMR 
spectrometer. Chemical shifts are quoted in parts per million (δ) referenced to the appropriate 
deuterated solvent employed. Multiplicities are indicated by s (singlet), d (doublet), t (triplet), q 
(quartet), quin (quintet), m (multiplet), br (broad) or combinations thereof. Coupling constant 
values are given in Hz. High resolution mass spectrometry was carried out  on a  ESI- UHR-
TOF  (Bruker Daltonics, Bremen (Germany)).  
 
Data were compared with literature data for compounds that had been previously reported. 
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3-Synthetic procedures 
 
Preparation of 2-aminoethyl 2-cyanoacetate hydrochloride, (4)1 
 
                                                           
 
Ethanolamine (1) (4.90 g, 0.08 mol), TEA (6.28 g, 0.06 mol) and DCM (123 mL) were added to 
a flame-dried flask, under inert atmosphere. The mixture was cooled in an ice-water bath and a 
solution of ditertbutyl dicarbonate (13.6 g, 0.06 mol) in DCM (5 ml) was added within 5 minutes.  
After the additional stirring for 2 hours, the reaction mixture was washed with 1M HCl at 0°C, 
10% NaHCO3 and organic layer dried over anh. MgSO4. After the removal of the solvent 
product (2) was obtained as an oily liquid. Compound (2) was further dissolved in dry THF (130 
mL) and cyanoacetic acid (42.0 g, 0.5 mol) was added at 0°C. After complete dissolution, N,N'-
Dicyclohexylcarbodiimide (DCC) (12.7 g, 0.06 mol) in dry THF (10 mL) was added over 2 
minute period of time and the reaction mixture was stirred overnight. Obtained precipitate was 
filtered off and thoroughly washed with ether.  Through ether filtrate containing the desired 
product (3) HCl gas was passed in order to remove the protecting group. The precipitate was 
filtered off giving 2-aminoethyl 2-cyanoacetate hydrochloride (4) (6.6 g, 65%, based on Boc2O) 
as a yellow solid.  
1H NMR (DMSO, 300 MHz): 8.26 (bs, 3H, NH3+), 4.34 (t, J = 5.1Hz, 2H), 4.09 (s, 2H), 3.06 (m, 
2H); 13C NMR (CDCl3, 75 MHz) δ 164.4, 114.9, 62.0, 37.5, 24.9; HRMS (ESI-MS): calculated for 
C5H8N2O2 129.0658, found 129.0657. 
 
Preparation of 4-(4,4-Difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene-8-yl)-
butyric acid, (7) 
                                                              
 
Glutaric acid anhydride (5) (0.31 g, 2.68 mmol), dry THF (45 mL), 2,4-dimethylpyrrole (6) (0.420 
g, 4.41mmol), and BF3·OEt2 (0.77 g, 5.40 mmol) were sequentially added to a nitrogen-flushed 
	   6 
two-necked flask. The mixture was heated to reflux for 5 h under nitrogen. After the mixture was 
cooled to room temperature, TEA (1.82 g, 17.9 mmol) and BF3·OEt2 (1.92 g, 13.5 mmol) were 
added slowly. The reaction mixture was stirred under nitrogen at room temperature for 24h. The 
resulting slurry was then extracted with DCM (3 x 150 mL) and combined organic layer washed 
with water (2 x 20 mL), dried over anhydrous Na2SO4 and evaporated. The obtained dark oil 
was purified by chromatography on silica gel (elution with hexane/ethyl acetate 2:1) to give 143 
mg (16%) of BODIPY-butyric acid (7) as a dark red solid. 
1H NMR (CDCl3, 300 MHz) δ 6.06 (s, 2H, pyrrole-H), 3.02 (t, 2H, -CH2, J = 8.6 Hz), 2.52 (t, 2H, -
CH2, J = 8.6 Hz), 2.43 (s, 6H, -CH3), 2.34 (s, 6H, -CH3), 1.92-1.98 (m, 2H, -CH2); 13C NMR 
(CDCl3, 75 MHz) δ 177.6, 154.3, 144.6, 140.4, 131.4, 121.9, 33.8, 27.4, 16.3, 14.4; HRMS (ESI-
MS):  [M-H]- calculated for C17H20BF2N2O2  333.1575, found 333.1580. 
 
Preparation of 4-(4,4-Difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene-8-yl) 
butyric acid NHS ester, (8)2 
                                                            
 
Compund (7) (0.07 g, 0.21 mmol) and N-hydroxysuccinimide (0.025 g, 0.23 mmol) were 
dissolved in anhydrous THF (3 mL). A solution of dicyclohexylcarbodiimide (0.025 g, 0.25 mmol) 
in anhydrous THF (1 mL) under dried condition was added to the previous solution slowly. 
Reaction mixture was agitated at room temperature for 5 h after what the obtained white 
precipitate was removed as a byproduct. The filtrate was evaporated under vacuum and the 
residue was purified by silica gel column chromatography with dichloromethane as eluent to 
give the desired red product (8) (0.09 g, yield 99 %).  
1H NMR (CDCl3, 300 MHz): 6.05 (s, 2H), 3.10–3.04 (m, 2H), 2.83 (s, 4H), 2.79–2.77 (m, 2H), 
2.50 (s, 6H), 2.40 (s, 6H), 2.09–2.03 (m, 2H); 13C NMR (CDCl3, 75 MHz) δ 169.0, 167.8, 154.4, 
144.0, 140.4, 131.3, 122.6, 121.9, 30.9, 27.0, 26.1, 25.5, 20.5, 16.4, 14.4; HRMS (ESI): 
calculated for C21H24BF2N3O4Na (M+Na+): 454.1726; C21H24BF2N3O4K 470.1465, found: 
454.1714 and 470.1463. 
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Preparation of CN-BOT3 
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2-aminoethyl 2-cyanoacetate hydrochloride (4) (39.05 mg, 0.24 mmol) and TEA (49.9 µL, 0.36 
mmol) were mixed in dry DMF (2.5 mL), to this solution compound (8) (52 mg, 0.12 mmol) was 
added and the mixture stirred for 24 h at room temperature under an argon atmosphere. The 
reaction mixture was quenched with saturated NH4Cl solution and then poured into ice-water to 
form the precipitate. The crude compound was purified by column chromatography on Al2O3 
(neutral) eluting by gradient elution with cyclohexane – dichloromethane system (1:2 to 0:1) to 
give CN-BOT (*46 mg, 85%) 
1H-NMR (300 MHz, CDCl3) δ 6.05 (s, 2H), 3.73 (t, J = 4.8 Hz, 2H), 3.42 (s, 2H), 3.02 (q,  J= 3.0 
Hz, 2H), 2.51(s, 6H), 2.42 (s, 6H), 2.3 (t, J = 4.8Hz, 2H), 1.98 (t, J = 8.1Hz, 2H), 1.83 (m, 2H); 
HRMS (ESI): calculated for C19H26BF2N3O2Na (M-COCH2CN+H+Na)+: 400.1984; found: 
400.1971.  
*Solvent is present as minor impurity (NMR spectra). 
 
Preparation of CN-Cy3 
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To a stirred solution of Cy3 (5 mg, 0.008 mmol) in anhydrous DMF (200 µL) freshly 
recrystallized 2-aminoethyl 2-cyanoacetate (4) (1.7 mg, 0.013 mmol) was added. Then 
trimethylamine (0.02 mmol, 2.3 µL) was added and the reaction mixture stirred overnight at 
room temperature.  The solvent was removed under vacuum and the residue purified by flash 
chromatography eluting with 100 % EtOAc and 2% to 10 % MeOH/CHCl3 to afford product CN-
Cy3 as a purple film (*3.8 mg, 80 %). 
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1H (CDCl3, 500 MHz): δ 8.93 (t, 1H,  J = 5 Hz); 8.42 (t, 1H, J = 10 Hz); 7.43-7.35 (m, 4H); 7.28-
7.21 (m, 4H); 7.14 (dd, 1H, J = 15, J = 10 Hz), 7.02 (d, 1H, J = 15 Hz), 4.33 (t, 2H, J = 5 Hz), 
4,13 (t, 2H, J = 7.5 Hz ), 4.02 (s, 2H), 3.80 (s, 3H), 3.57-3.53 (m, 2H), 2.46 (t, 2H, J = 7.5 Hz), 
1.93-1.83 (m, 4H), 1.73 (s, 6H), 1.72 (s, 6H), 1.70-1.58 (m, 2H). 
*Diethyl ether is present as minor impurity (NMR spectra). 
 
 
4-Additional References 
(1) Mcardle, C. B., et al. Activated methylene reagents and curable compositions prepared 
therefrom, 2009, WO2009053482 A3. 
(2) a) Zhang Z.X., Gao P.F, Guo X.F., Wang H.,  Zhang H.S. Anal Bioanal Chem 2011, 401, 
905–1914;  b) Meng Q., Yu M., Zhang H., Ren J., Huang D. Dyes and Pigments 2007, 73, 254-
260. 
(3) Li Z., Mintzer E., Bittman R.  J Org Chem 2006, 71, 1718–1721. 
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5-Supporting Figures 
 
Figure S1. Analysis of the MS data shown in the Figure 1A-C. 
Figure S2. Analysis of the MS data shown in Figure 1D-F. 
Figure S3. H2S release form NAP-SSH treated with Trx. 
Figure S4. MS analysis of the reaction mixture containing 20 µM Trx and 40 µM HSA-SSH 
reveals a complete oxidation of Trx. 
Figure S5. Plot of kobs vs. concentration of the used LMW species for the reaction with Trx (E. 
coli). 
Figure S6. UV-vis and fluorescence spectral properties of HSA-SSH labelled with improved tag-
switch method probes, CN-Cy3 and CN-BOT. 
Figure S7. Comparison of tag-switch labelling (CN-Biotin) with improved tag-switch labelling 
(CN-Cy3). 
Figure S8. Validation of CN-BOT based tag-switch method. 
Figure S9. Inhibition of H2S production leads to decrease of persulfidation in the cell lysates, as 
observed by improved CN-Cy3 based tag-switch assay. 
Figure S10. Isotope dilution MS method for sulfane sulphur quantification. 
Figure S11. Sulfane sulphur levels vs. viral load. 
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Figure S1. Analysis of the MS data shown in the Figure 1A-C. A) Observed (black) and 
simulated (red) isotopic distribution for NAP-SSH (m/z 240.0347; calculated 240.0359). B-C) 
MS spectra at t=0 (B) and t=5 min (C) of the reaction mixture containing 50 µM NAP-SSH and 
50 µM Trx (E. coli) in ammonium carbonate buffer pH 7.38, indicate formation of NAPSH which 
ionizes as [NAPSH + H]+ and [NAPSH + NH4]+. D) Observed (black) and simulated (red) 
isotopic distribution for [NAPSH + H]+ (m/z 208.0623; calculated 208.0638). E) Observed (blue) 
and simulated (red) isotopic distribution for [NAPSH + NH4]+ (225.0883; calculated 225.0904). 
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Figure S2. Analysis of the MS data shown in Figure 1D-F. A) Mass spectrum of fully reduced 
Trx. B) Deconvoluted MS spectrum shows the parent peak which corresponds to [Trxred + H]+ 
and subsequent peaks which correspond to the addition of 1 to 3 Na+ ions. C) Mass spectrum of 
the Trx after 2 min of incubation with NAPSSH. D) Deconvoluted spectra which corresponds to 
[Trxox + H]+ followed by the peaks which correspond to the addition of 1 to 3 Na+ ions. 
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Figure S3. H2S release form NAP-SSH treated with Trx. 100 µM NAP-SSH was added into 
PBS solution (pH 7.4) with H2S electrode immersed in it (blue circles). No significant change in 
the electrode response could be observed. When 10 µM Trx was added into PBS solution (pH 
7.4) with H2S electrode immersed in it (red circles) no significant change in the electrode 
response could be observed either. However, subsequent injection of 100 µM NAP-SSH led to 
an immediate electrode response which correlates with the amount of released H2S. 
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Figure S4. MS analysis of the reaction mixture containing 20 µM Trx and 40 µM HSA-SSH 
reveals a complete oxidation of Trx. A) Full MS spectrum showing differently charged Trx 
species. Due to the high ionizability of Trx and lower charge/molecule ratio, it was not possible 
to deconvolute the spectra of HSA in the same reaction mixture. HSA can be noticed in the 
spectrum as a regular pattern of signals in m/z 1500-2000 range. B) Deconvoluted spectrum 
showing [Trxox + H]+, [Trxox + Na]+, [Trxox - H + 2Na]+ and [Trxox - 2H + 3Na]+. C) Observed 
isotopic distribution (red) and simulated isotopic distribution for [Trxox + H]+. 
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Figure S5. Plot of kobs vs. concentration of the used LMW species for the reaction with 
Trx (E. coli). Reaction was followed fluorimetrically measuring conformational changes induced 
in Trx due to the cysteine oxidation (See Figure 2F). 
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Figure S6. UV-vis and fluorescence spectral properties of HSA-SSH labelled with 
improved tag-switch method probes, CN-Cy3 and CN-BOT. A) UV-vis spectra of 67 µM 
HSA-SSH labelled with CN-Cy3 (red) and 75 µM free CN-Cy3 (blue). B) Emission spectrum of 
100 µM HSA-SSH labelled with CN-Cy3 (λex 542 nm). C) UV-vis spectra of 67 µM HSA-SSH 
labelled with CN-BOT (red) and 51 µM free CN-BOT (blue). D) Emission spectrum of 100 µM 
HSA-SSH labelled with CN-BOT (λex 494 nm). 
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Figure S7. Comparison of tag-switch labelling (CN-Biotin) with improved tag-switch 
labelling (CN-Cy3). A) Human red blood cell lysates were labelled with either CN-Biotin and 
analysed by Western Blot or labelled with CN-Cy3 and in-gel fluorescence was detected. The 
same protein load is used for both experiments (20 µg). B) Proteins of red blood cell 
membranes visualized either by Western Blot or in-gel fluorescence. C) D. melanogaster head 
homogenates were labelled for persulfidation using either CN-Biotin or CN-Cy3 in the last step. 
The same protein amount was loaded (10 µg) in two separate gels and the bands visualized 
accordingly. 
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Figure S8. Validation of CN-BOT based tag-switch method. A) BAECs were fixed with 
methanol, delipidated with acetone and incubated with or without MSBT prior the exposure to 
CN-BOT. No detectable signal could be seen in the cells not treated with MSBT under the 
recording conditions where signal could be observed in the control cells and an increase of the 
signal in the cells treated with H2S. Scale bar 50 µm. B) When laser intensity was increased 20 
fold the nonspecific signal could be seen even in the cells treated only with CN-BOT. However, 
the intensity is still smaller than the one observed in the control cells recorded under normal 
condition. Even more, the pattern of the fluorescence is also different indicating that there is a 
weak nonspecific binding of the dye to the cell preparations. Scale bar 20 µm. C) BAECs 
incubated with 2 mM propargylglycine (PG) for 1 h show significantly lower intracellular 
persulfide levels (lower lane). Scale bar 10 µm. 
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Figure S9. Inhibition of H2S production leads to decrease of persulfidation in the cell 
lysates, as observed by improved CN-Cy3 based tag-switch assay. A) SH-SY5Y cells were 
incubated with 2 mM AOAA for 4 h, mean ± S.D., n=3, *p<0.001. B) BAEC were incubated with 
2 mM PG for 4 h, mean ± S.D., n=3, *p<0.001. Pseudo-colouring of the gels was used to better 
visually indicate the differences in the signal intensities. Colour scale is given in the figure. 
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Figure S10. Isotope dilution MS method for sulfane sulphur quantification. A) Structures 
of probe 1 and probe 2 used for the isotope dilution method and the schematic representation of 
the methodology. B) Representative MS spectra of the control BAEC lysates (left) or of the 
lysates obtained from the BAECs treated with 2 µM auranofin for 1 h (right). The arrows point to 
the m/z of the detected product and isotope labelled internal standard. C) Observed (red) and 
simulated (black) isotope distribution for m/z 446.0956 peak corresponding to the [1=S + Na]+. 	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Figure S11. Sulfane sulfur levels vs. HIV-1 viral load. HIV-1 viral load is given as copies/ml. 
Values <20 copies/ml are indicated in the graph as 19 copies/ml.  
(the detection limit of the PCR is 20 copies/ml). Spearman correlation: correlation coefficient: -
0.9344, p=0.000. 
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6-Supporting Tables 
 
Table S1. Basic patients characteristics.	  
	  	  
m: male; f: female; CDC:  CDC stage of HIV-1-infection; CD4:  CD4+ T-cells/µl; CD8: CD8+ T-
cells /µl; VL: HIV-1 viral load in plasma in copies/ml plasma; sulfane sulphur levels in pmol/mg 
of plasma protein; ART: antiretroviral therapy; pat#2 is treated for diabetes with metformin, 
sitagliptin, levemir and ASS;  pat#9 suffers from chronic hepatitis C (HCV viral load 340 000 
copies/ml). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
!
Patient 
number sex age CDC CD4 
viral 
load ART 
sulfane 
sulphur 
pmol/mg 
#1 f 43 B3 707 <20 yes 10 
#2 m 50 A2 331 <20 yes 15 
#3 m 36 B3 309 <20 yes 9 
#4 m 46 C3 364 <20 yes 17 
#5 f 53 C3 955 <20 yes 11 
#6 m 27 A1 684 13000 no 3 
#7 m 37 A1 531 8400 no 5 
#8 m 29 B2 143 37000 no 1.5 
#9 m 34 A3 182 2600 no 6 
#10 m 42 B2 395 5400000 no 2 
#11 f 39 A2 476 4300 no 4 
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7-Product Characterization 
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Current Data Parameters
NAME           sw0909qa                
EXPNO                11                
PROCNO                1                
F2 - Acquisition Parameters
Date_           20130909                
Time              11.29                
INSTRUM           spect                
PROBHD   5 mm QNP  1H/1                
PULPROG          zgpg30                
TD                32768                
SOLVENT           CDCl3                
NS                 1000                
DS                    4                
SWH           21097.047 Hz             
FIDRES         0.643831 Hz             
AQ            0.7766516 sec            
RG                16384                
DW               23.700 usec           
DE                 6.00 usec           
TE                297.2 K              
D1           2.00000000 sec            
d11          0.03000000 sec            
DELTA        1.89999998 sec            
TD0                   1                
======== CHANNEL f1 ========
NUC1                13C                
P1                 8.40 usec           
PL1               -3.00 dB             
SFO1         75.4768051 MHz            
======== CHANNEL f2 ========
CPDPRG2         waltz16                
NUC2                 1H                
PCPD2             89.00 usec           
PL2               -6.00 dB             
PL12              11.12 dB             
PL13              17.00 dB             
SFO2        300.1312005 MHz            
F2 - Processing parameters
SI                32768                
SF           75.4677490 MHz            
WDW                  EM                
SSB                   0                
LB                 1.00 Hz             
GB                    0                
PC                 1.40  
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